Cargando…

The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock

BACKGROUND: Dengue infection is one of the problems in the national health sector in Indonesia because the incidence and mortality in Indonesia due to dengue infection is still very high. In 2005 Indonesia became the highest contributor to dengue infection in Southeast Asia (53%) with 95.270 people...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariko, Rinang, Darwin, Eryati, Yanwirasti, Yanwirasti, Hadinegoro, Sri Rezeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698111/
https://www.ncbi.nlm.nih.gov/pubmed/31456836
http://dx.doi.org/10.3889/oamjms.2019.569
_version_ 1783444497504403456
author Mariko, Rinang
Darwin, Eryati
Yanwirasti, Yanwirasti
Hadinegoro, Sri Rezeki
author_facet Mariko, Rinang
Darwin, Eryati
Yanwirasti, Yanwirasti
Hadinegoro, Sri Rezeki
author_sort Mariko, Rinang
collection PubMed
description BACKGROUND: Dengue infection is one of the problems in the national health sector in Indonesia because the incidence and mortality in Indonesia due to dengue infection is still very high. In 2005 Indonesia became the highest contributor to dengue infection in Southeast Asia (53%) with 95.270 people and 1.298 deaths. AIM: This study aims to analyse differences in angiopoietin-2 levels in dengue hemorrhagic fever (DHF) with and without shock. METHODS: This study was a consecutive sampling design with the research subject was obtained based on the order of admission to the hospital — the serum Angiopoietin-2 levels using the ELISA method. The statistical test used is the independent t-test. The value of p < 0.05 was said to be statistically significant. RESULT: The result showed that the mean of Angiopoietin-2 levels in DHF patients with shock was higher than in DHF (p < 0.05). CONCLUSION: This study concluded that there was a difference in the average level of Angiopoietin-2 among DHF patients with shock compared to without shock.
format Online
Article
Text
id pubmed-6698111
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Republic of Macedonia
record_format MEDLINE/PubMed
spelling pubmed-66981112019-08-27 The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock Mariko, Rinang Darwin, Eryati Yanwirasti, Yanwirasti Hadinegoro, Sri Rezeki Open Access Maced J Med Sci Clinical Science BACKGROUND: Dengue infection is one of the problems in the national health sector in Indonesia because the incidence and mortality in Indonesia due to dengue infection is still very high. In 2005 Indonesia became the highest contributor to dengue infection in Southeast Asia (53%) with 95.270 people and 1.298 deaths. AIM: This study aims to analyse differences in angiopoietin-2 levels in dengue hemorrhagic fever (DHF) with and without shock. METHODS: This study was a consecutive sampling design with the research subject was obtained based on the order of admission to the hospital — the serum Angiopoietin-2 levels using the ELISA method. The statistical test used is the independent t-test. The value of p < 0.05 was said to be statistically significant. RESULT: The result showed that the mean of Angiopoietin-2 levels in DHF patients with shock was higher than in DHF (p < 0.05). CONCLUSION: This study concluded that there was a difference in the average level of Angiopoietin-2 among DHF patients with shock compared to without shock. Republic of Macedonia 2019-07-13 /pmc/articles/PMC6698111/ /pubmed/31456836 http://dx.doi.org/10.3889/oamjms.2019.569 Text en Copyright: © 2019 Rinang Mariko, Eryati Darwin, Yanwirasti Yanwirasti, Sri Rezeki Hadinegoro. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
spellingShingle Clinical Science
Mariko, Rinang
Darwin, Eryati
Yanwirasti, Yanwirasti
Hadinegoro, Sri Rezeki
The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
title The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
title_full The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
title_fullStr The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
title_full_unstemmed The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
title_short The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
title_sort difference of angiopoietin-2 levels between dengue hemorrhagic fever patients with shock and without shock
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698111/
https://www.ncbi.nlm.nih.gov/pubmed/31456836
http://dx.doi.org/10.3889/oamjms.2019.569
work_keys_str_mv AT marikorinang thedifferenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock
AT darwineryati thedifferenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock
AT yanwirastiyanwirasti thedifferenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock
AT hadinegorosrirezeki thedifferenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock
AT marikorinang differenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock
AT darwineryati differenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock
AT yanwirastiyanwirasti differenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock
AT hadinegorosrirezeki differenceofangiopoietin2levelsbetweendenguehemorrhagicfeverpatientswithshockandwithoutshock